BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Psilocybin

The major of two hallucinogenic components of the sacred Teonanacatl mushrooms (see PSILOCYBE), the other component being PSILOCIN.

300+ PubMed studies analyzed · 25 RCTs · Evidence Score: 53.7

Research Domains

Psilocybin has been studied across 14 research domains including 🌤️ Mood & Depression, 🧘 Stress & Anxiety, ⏳ Longevity & Aging, 🔬 Oncology, 🧠 Cognitive. The primary research focus is 🌤️ Mood & Depression with 52% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Psilocybin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

sb
3 shared targets
rs
3 shared targets
nn
3 shared targets
lorcaserin
3 shared targets
sb
3 shared targets
Encainide
3 shared targets
pimavanserin
2 shared targets
pizotyline
3 shared targets
mesulergine
3 shared targets
glaucine
3 shared targets
Loading evidence profile...

This evidence profile for Psilocybin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.